Reliance Industries, Cipla, Biocon: 7 large-cap stocks at 52-week low! Should you buy the dip?

Story by: Tanya Aneja 
Designed by: Pragati

With a market capitalisation of more than Rs 15 lakh crore, the shares of Reliance Industries Limited tanked 7% to hit their 52-week low of Rs 2,269.65 on March 14, 2023, on the Bombay Stock Exchange (BSE)

Reliance Industries Limited

Page Industries

Shares of Page Industries fell 2% to hit their 52-week low of Rs 35,600 on BSE on March 14, 2023. The stock is one of the most expensive on Dalal Street

Cipla stock tanked 2% to hit a 52-week low of Rs 853.50 on BSE on March 14, 2023. The stock took a beating amid a media report that stated the Income Tax Department was investigating Cipla on charges of tax violations and tax avoidance

Cipla

Biocon

Biocon stock fell 1% to hit a 52-week low of Rs 216.20 on March 14, 2023, on BSE. It ended 0.30% lower at Rs 217.60

Shares of HDFC Life Insurance company tanked 2% to hit a 52-week low of Rs 468.80 on March 14, 2023, on BSE. The market cap of the firm fell to Rs 1,01,202.79 crore

HDFC Life Insurance company

Tata Consumer stock also hit a 52-week low of Rs 690 on March 14, 2023, on BSE. The stock ended 0.19% lower at Rs 694

Tata Consumer

Shares of Divi's Laboratories fell 1% to hit a 52-week low of Rs 2,730 on March 14, 2023, on BSE. The stock ended 0.26% lower at Rs 2,760.95

Divi's Laboratories

"It could be a good time to accumulate large-cap stocks which are available currently at discounted prices. We also believe that midcaps are likely to outperform the market in the days ahead," says Arvinder Singh Nanda, Senior Vice President, Master Capital Services

Master Capital Services
on recent lows

“One shouldn’t see a new 52-week low or record low as a buying opportunity until we have a strong rationale in place," says Ajit Mishra, VP-Technical Research, Religare Broking

Religare Broking on
recent lows

The stocks mentioned in the story are for information purposes only. Investors or market participants should consult their financial advisors before taking any position

Disclaimer